Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Biologics Center Performance To Be Reviewed By Advisory Committees

Executive Summary

The Center for Biologics Evaluation & Research will use its advisory committees to perform an external review of its operations

You may also be interested in...



FDA Oncology Therapeutics Office Will Contain Three Divisions

FDA's proposed oncology therapeutics office will be organized into three divisions, Center for Drug Evaluation & Research Medical Policy Director Robert Temple, MD, said June 17 during a Drug Information Association meeting in Washington, D.C

CBER Review Template Initiative Aimed At Improving Consistency

The Center for Biologics Evaluation & Research is developing review templates in an effort to improve product reviews

BioShield House Compromise Could Serve As Template For Senate

The House Energy & Commerce Committee and White House funding compromise for Project BioShield could serve as a template for agreement in the Senate

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel